Overview

The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
PPI test;empirical trial with high-dose proton-pump inhibitors (PPIs) has been shown to be a sensitive tool for diagnosing patients with GERD. However, this diagnostic strategy has not been well established in patients with extraesophageal manifestation of GERD. In this study, we aim to see the relevance of PPI test in diagnosing GERD in patients with extraesophageal symptoms.
Phase:
N/A
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Proton Pump Inhibitors
Rabeprazole